BioAge Investors Lose Last Bid At Obesity Drug-Linked Suit

By Sydney Price · March 3, 2026, 8:37 PM EST

Biopharmaceutical company BioAge Labs Inc. has escaped a suit accusing it of damaging investors by unexpectedly halting a clinical trial for a weight loss drug, with a California federal judge finding...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re BioAge Labs, Inc., Securities Litigation

Case Number

3:25-cv-00196

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 07, 2025